Zdrowie i gospodarka · 29/03/2018
FDA Announces Revised Draft Guidance for Generic Doxycycline Hyclate Oral Delayed-Release Tablets
The FDA is releasing a revised draft guidance for the pharmaceutical industry on generic doxycycline hyclate oral delayed-release tablets, outlining product-specific recommendations for bioequivalence studies to support abbreviated new drug applications.